
Healthcare / Pharmaceuticals Sector · BSE
Chandra Bhagat Pharma Limited, established in 2003, is engaged in marketing lifesaving medicines in India across therapeutic areas such as cardiovascular care, cancer treatment, antibiotics, hormones, anesthesia, pediatrics, nephrology, antiviral, antifungal, and neurology. The company operates under its own brand with the support of an in-house sales team and distribution network that supplies healthcare centers and hospitals, while also dealing in specialty chemicals. In addition to finished formulations, it imports, supplies, and undertakes indenting of active pharmaceutical ingredients and intermediates, and holds FDA approval to manufacture formulations through contract manufacturers. Its storage facilities are located on a leased basis in Bhiwandi, Thane, Maharashtra, and the company also exports pharmaceutical products to international markets including DR Congo, Bolivia, and the Philippines.
Price Band
₹51
Issue Size
₹10.20 Cr
Lot Size
2000 shares
GMP
Est. Listing
₹51
at current GMP
Subscribed
—
Open
31 Jan 2020
Close
6 Feb 2020
Allotment
12 Feb 2020
Refund
13 Feb 2020
Demat Credit
14 Feb 2020
Listing
14 Feb 2020
Designated Registrar: Link Intime India Private Limited
Allotment Date
12 Feb 2020
Basis finalization
Refunds Initiate
13 Feb 2020
Mandate release
Demat Credit
14 Feb 2020
Shares in demat
Listing Debut
14 Feb 2020
Trading begins
Chandra Bhagat Pharma Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals Sector sector with an aggregate issue size of ₹10.2 Crores. The shares are offered at a price band of ₹51 to ₹51 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,02,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2020-02-14, while un-allotted funds or UPI block mandates will be released on 2020-02-13.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.